The stimulation of POMC/CART neurons promotes satiety (62)
The Centers for Medicare & Medicaid Services has launched the Medicare GLP-1 Bridge pilot program, giving eligible Medicare Part D beneficiaries access to select GLP-1 medications for $50 per month from July 1, 2026, through December 31, 2027
Increased serotonin production may contribute to behavioral abnormalities, migraine, headaches, and changes in cerebral blood flow [2]
The mentioned potential benefits hold true in general for any transdermal delivery system and not GLP- patches specifically, as these still lack real-world evidence
While nausea is common, vomiting occurs less frequently and varies widely from person to person
Conclusion Nausea is a common but manageable side effect of GLP-1 agonists